Broad, Bayer expand partnership to develop therapies for heart failure

This article was originally published here

The Broad Institute of MIT and Harvard and Bayer are launching the Precision Cardiology Laboratory (PCL), a new endeavor that will pursue scientific insights aimed at developing new therapies for heart failure.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply